keyword
https://read.qxmd.com/read/38631806/the-spectrum-of-postacute-sequelae-of-covid-19-in-children-from-mis-c-to-long-covid
#1
REVIEW
Abigail S Kane, Madeleine Godfrey, Magali Noval Rivas, Moshe Arditi, Alessio Fasano, Lael M Yonker
The effects of SARS-CoV-2 infection on children continue to evolve following the onset of the COVID-19 pandemic. Although life-threatening multisystem inflammatory syndrome in children (MIS-C) has become rare, long-standing symptoms stemming from persistent immune activation beyond the resolution of acute SARS-CoV-2 infection contribute to major health sequelae and continue to pose an economic burden. Shared pathophysiologic mechanisms place MIS-C and long COVID within a vast spectrum of postinfectious conditions characterized by intestinal dysbiosis, increased gut permeability, and varying degrees of immune dysregulation...
April 17, 2024: Annual Review of Virology
https://read.qxmd.com/read/38619077/recommendations-for-the-management-of-initial-and-refractory-pediatric-status-dystonicus
#2
REVIEW
Lindsey M Vogt, Kathryn Yang, Gabriel Tse, Vicente Quiroz, Zainab Zaman, Laura Wang, Rasha Srouji, Amy Tam, Elicia Estrella, Shannon Manzi, Alfonso Fasano, Weston T Northam, Scellig Stone, Mahendranath Moharir, Hernan Gonorazky, Brian McAlvin, Monica Kleinman, Kerri L LaRovere, Carolina Gorodetsky, Darius Ebrahimi-Fakhari
Status dystonicus is the most severe form of dystonia with life-threatening complications if not treated promptly. We present consensus recommendations for the initial management of acutely worsening dystonia (including pre-status dystonicus and status dystonicus), as well as refractory status dystonicus in children. This guideline provides a stepwise approach to assessment, triage, interdisciplinary treatment, and monitoring of status dystonicus. The clinical pathways aim to: (1) facilitate timely recognition/triage of worsening dystonia, (2) standardize supportive and dystonia-directed therapies, (3) provide structure for interdisciplinary cooperation, (4) integrate advances in genomics and neuromodulation, (5) enable multicenter quality improvement and research, and (6) improve outcomes...
April 15, 2024: Movement Disorders: Official Journal of the Movement Disorder Society
https://read.qxmd.com/read/38605039/neural-signatures-of-indirect-pathway-activity-during-subthalamic-stimulation-in-parkinson-s-disease
#3
JOURNAL ARTICLE
Leon A Steiner, David Crompton, Srdjan Sumarac, Artur Vetkas, Jürgen Germann, Maximilian Scherer, Maria Justich, Alexandre Boutet, Milos R Popovic, Mojgan Hodaie, Suneil K Kalia, Alfonso Fasano, William D Hutchison Wd, Andres M Lozano, Milad Lankarany, Andrea A Kühn, Luka Milosevic
Deep brain stimulation (DBS) of the subthalamic nucleus (STN) produces an electrophysiological signature called evoked resonant neural activity (ERNA); a high-frequency oscillation that has been linked to treatment efficacy. However, the single-neuron and synaptic bases of ERNA are unsubstantiated. This study proposes that ERNA is a subcortical neuronal circuit signature of DBS-mediated engagement of the basal ganglia indirect pathway network. In people with Parkinson's disease, we: (i) showed that each peak of the ERNA waveform is associated with temporally-locked neuronal inhibition in the STN; (ii) characterized the temporal dynamics of ERNA; (iii) identified a putative mesocircuit architecture, embedded with empirically-derived synaptic dynamics, that is necessary for the emergence of ERNA in silico; (iv) localized ERNA to the dorsal STN in electrophysiological and normative anatomical space; (v) used patient-wise hotspot locations to assess spatial relevance of ERNA with respect to DBS outcome; and (vi) characterized the local fiber activation profile associated with the derived group-level ERNA hotspot...
April 11, 2024: Nature Communications
https://read.qxmd.com/read/38595691/examining-short-interval-intracortical-inhibition-with-different-transcranial-magnetic-stimulation-induced-current-directions-in-als
#4
JOURNAL ARTICLE
Roisin McMackin, Yasmine Tadjine, Antonio Fasano, Matthew Mitchell, Mark Heverin, Friedemann Awiszus, Bahman Nasseroleslami, Richard G Carson, Orla Hardiman
OBJECTIVE: To establish if induced current direction across the motor cortex alters the sensitivity of transcranial magnetic stimulation (TMS)-evoked short-interval intracortical inhibition (SICI) as an ALS biomarker. METHODS: Threshold tracking-TMS was undertaken in 35 people with ALS and 39 controls. Using a coil orientation which induces posterior-anterior (PA)-directed current across the motor cortex, SICI (1 ms and 3 ms interstimulus intervals) and intracortical facilitation (ICF, 10 ms interstimulus interval) were recorded...
2024: Clinical Neurophysiology Practice
https://read.qxmd.com/read/38594640/assessment-of-the-fret-based-teen-sensor-to-monitor-erk-activation-changes-preceding-morphological-defects-in-a-rasopathy-zebrafish-model-and-phenotypic-rescue-by-mek-inhibitor
#5
JOURNAL ARTICLE
Giulia Fasano, Stefania Petrini, Valeria Bonavolontà, Graziamaria Paradisi, Catia Pedalino, Marco Tartaglia, Antonella Lauri
BACKGROUND: RASopathies are genetic syndromes affecting development and having variable cancer predisposition. These disorders are clinically related and are caused by germline mutations affecting key players and regulators of the RAS-MAPK signaling pathway generally leading to an upregulated ERK activity. Gain-of-function (GOF) mutations in PTPN11, encoding SHP2, a cytosolic protein tyrosine phosphatase positively controlling RAS function, underlie approximately 50% of Noonan syndromes (NS), the most common RASopathy...
April 9, 2024: Molecular Medicine
https://read.qxmd.com/read/38587242/antibiotic-prophylaxis-in-invasive-urodynamics-a-delphi-consensus-of-the-italian-society-of-urodynamics-siud
#6
JOURNAL ARTICLE
Emanuele Rubilotta, Elisabetta F Chiarulli, Enrico Ammirati, Marianna C Bevacqua, Stefano Manodoro, Stefania Chierchia, Eugenia Fragalà, Giuseppe Masiello, Vincenzo L Marzi, Alessandro Giammò, Stefania Musco, Francesco Savoca, Matteo Balzarro, Cosimo De Nunzio, Gaetano De Rienzo, Ferdinando Fusco, Gianfranco Lamberti, Marco Soligo, Luisa De Palma, Massimo Fasano, Anna Carretta, Fabio Tumietto, Enrico Finazzi-Agrò, Eleonora Russo, Alessandro Antonelli, Marilena Gubbiotti, Gianluca Sampogna, Michele Spinelli, Roberto Carone, Leonardo Martino, Vito Mancini
INTRODUCTION: Although antibiotic prophylaxis (AB) demonstrated a statistically significant reduction in bacteriuria after invasive urodynamics (UDS), no significant decrease in the incidence of urinary tract infections (UTI) has been confirmed. No absolute recommendations on the use of AB in case of relevant potential risk of UTI have been reported, though some categories of patients at increased infective probability after UDS have been recognized. The aim of this study is to report the experts' consensus on the best practice for the use of AB before UDS in the main categories of patients at potential risk of developing UTI...
April 8, 2024: Neurourology and Urodynamics
https://read.qxmd.com/read/38579736/finite-size-effects-in-hyperuniform-vortex-matter
#7
JOURNAL ARTICLE
Rocío Milagros Besana, Federico Elías, Joaquı N Roberto Puig, Jazmı N Aragón Sánchez, Gladys Nieva, Alejandro Benedykt Kolton, Yanina Fasano
Novel hyperuniform materials are emerging as an active field of applied and basic research since they can be designed to have exceptional physical properties. This ubiquitous state of matter presents a hidden order that is characterized by the density of constituents of the system being uniform
at large scales, as in a perfect crystal, although they can be isotropic and disordered like a liquid. In the quest for synthesizing hyperuniform materials in experimental conditions, the impact of finite-size effects remains as an open question to be addressed...
April 5, 2024: Journal of Physics. Condensed Matter: An Institute of Physics Journal
https://read.qxmd.com/read/38568334/blood-lead-levels-and-their-association-with-iron-deficiency-and-anemia-in-children
#8
JOURNAL ARTICLE
Liliana Disalvo, Ana Varea, Natalia Matamoros, Marisa Sala, María V Fasano, Horacio F González
Lead is a ubiquitous and neurotoxic heavy metal particularly harmful to children, who are more susceptible than adults to its toxic effects. The prevalence of lead poisoning and iron deficiency (ID) is high in socioeconomically vulnerable child populations, negatively affecting neurocognitive development in children. Although numerous studies have shown the association between blood lead levels (BLL) and ID, the issue remains controversial. Here, we aimed to identify the association between BLL and iron nutritional status in children...
April 3, 2024: Biological Trace Element Research
https://read.qxmd.com/read/38552355/generation-of-ipscs-from-identical-twin-one-affected-by-lhon-and-one-unaffected-both-carrying-a-combination-of-two-mitochondrial-variants-m-14484%C3%A2-t-c-and-m-10680g-a
#9
JOURNAL ARTICLE
Camille Peron, Andrea Cavaliere, Chiara Fasano, Angelo Iannielli, Manuela Spagnolo, Andrea Legati, Maria Nicol Colombo, Ambra Rizzo, Francesca L Sciacca, Valerio Carelli, Vania Broccoli, Costanza Lamperti, Valeria Tiranti
Leber hereditary optic neuropathy (LHON) is one of the most common mitochondrial illness, causing retinal ganglion cell degeneration and central vision loss. It stems from point mutations in mitochondrial DNA (mtDNA), with key mutations being m.3460G > A, m.11778G > A, and m.14484 T > C. Fibroblasts from identical twins, sharing m.14484 T > C and m.10680G > A variants each with 70 % heteroplasmy, were used to generate iPSC lines...
March 24, 2024: Stem Cell Research
https://read.qxmd.com/read/38533492/early-host-immune-responses-in-a-human-organoid-derived-gallbladder-monolayer-to-salmonella-typhi-strains-from-patients-with-acute-and-chronic-infections-a-comparative-analysis
#10
JOURNAL ARTICLE
Rosângela Salerno-Goncalves, Haiyan Chen, Andrea C Bafford, Mariana Izquierdo, Juan Carlos Hormazábal, Rosanna Lagos, Hervé Tettelin, Adonis D'Mello, Jayaum S Booth, Alessio Fasano, Myron M Levine, Marcelo B Sztein
Salmonella enterica serovar Typhi ( S . Typhi), a human-restricted pathogen, invades the host through the gut to cause typhoid fever. Recent calculations of the typhoid fever burden estimated that more than 10 million new typhoid fever cases occur in low and middle-income countries, resulting in 65,400-187,700 deaths yearly. Interestingly, if not antibiotic-treated, upon the resolution of acute disease, 1%-5% of patients become asymptomatic chronic carriers. Chronically infected hosts are not only critical reservoirs of infection that transmit the disease to naive individuals but are also predisposed to developing gallbladder carcinoma...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38524423/electrochemical-synthesis-of-unnatural-amino-acids-embedding-5-and-6-membered-heteroaromatics
#11
JOURNAL ARTICLE
Elena Bombonato, Valerio Fasano, Daniel Pecorari, Luca Fornasari, Francesco Castagnini, Massimo Marcaccio, Paolo Ronchi
Using a commercially available potentiostat, the electrochemical synthesis of unnatural amino acids bearing heteroaromatics on the lateral chain has been accomplished. This strategy exploits the side-chain decarboxylative arylation of aspartic/glutamic acid, a reaction that becomes challenging with electron-rich coupling partners such as 5- and 6-membered heteroaromatics. These rings are underrepresented in unnatural amino acids, therefore allowing a wider exploration of the chemical space, given the abundance of the aryl bromides employable in this reaction...
March 19, 2024: ACS Omega
https://read.qxmd.com/read/38518273/psychedelic-therapy-a-primer-for-primary-care-clinicians-the-strengths-weaknesses-opportunities-and-threats-of-psychedelic-therapeutics
#12
JOURNAL ARTICLE
Owen S Muir, Kenneth Shinozuka, Bryce D Beutler, Alejandro Arenas, Kirsten Cherian, Viviana D Evans, Chelsey Fasano, Burton J Tabaac
The reviews in this special edition have presented a primer on the state of the literature for 7 different psychedelic compounds and their plausible roles in medicine. In a common format underscoring strengths, weakness, opportunities, and threats (SWOT), this article addresses how psychedelic compounds fit into the broader health care landscape for indicated conditions. Historically, psychiatric pathologies have been treated with small-molecule compounds that have limited effect sizes and carry a variety of adverse effect profiles...
March 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38518272/psychedelic-therapy-a-primer-for-primary-care-clinicians-ketamine
#13
JOURNAL ARTICLE
Viviana D Evans, Alejandro Arenas, Kenneth Shinozuka, Burton J Tabaac, Bryce D Beutler, Kirsten Cherian, Chelsey Fasano, Owen S Muir
BACKGROUND: Ketamine, an arylcyclohexylamine dissociative anesthetic agent, has evolved into a versatile therapeutic. It has a rapid-onset, well-understood cardiovascular effects and a favorable safety profile in clinical use. Its enantiomeric compound, esketamine, was approved by the Food and Drug Administration in 2019 for both treatment-resistant depression and major depressive disorder with suicidal ideation. AREAS OF UNCERTAINTY: Research indicates dose-dependent impacts on cognition, particularly affecting episodic and working memory following both acute administration and chronic use, albeit temporarily for the former and potentially persistent for the latter...
March 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38518271/psychedelic-therapy-a-primer-for-primary-care-clinicians-3-4-methylenedioxy-methamphetamine-mdma
#14
JOURNAL ARTICLE
Kenneth Shinozuka, Burton J Tabaac, Alejandro Arenas, Bryce D Beutler, Kirsten Cherian, Viviana D Evans, Chelsey Fasano, Owen S Muir
BACKGROUND: After becoming notorious for its use as a party drug in the 1980s, 3,4-methylenedioxy-methampetamine (MDMA), also known by its street names "molly" and "ecstasy," has emerged as a powerful treatment for post-traumatic stress disorder (PTSD). AREAS OF UNCERTAINTY: There are extensive data about the risk profile of MDMA. However, the literature is significantly biased. Animal models demonstrating neurotoxic or adverse effects used doses well beyond the range that would be expected in humans (up to 40 mg/kg in rats compared with roughly 1-2 mg/kg in humans)...
March 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38518270/psychedelic-therapy-a-primer-for-primary-care-clinicians-ibogaine
#15
JOURNAL ARTICLE
Kirsten Cherian, Kenneth Shinozuka, Burton J Tabaac, Alejandro Arenas, Bryce D Beutler, Viviana D Evans, Chelsey Fasano, Owen S Muir
BACKGROUND: Ibogaine is a plant-derived alkaloid that has been used for thousands of years in rites of passage and spiritual ceremonies in West-Central Africa. In the West, it has primarily been used and studied for its anti-addictive properties and more recently for other neuropsychiatric indications, including post-traumatic stress disorder, depression, anxiety, and traumatic brain injury. AREAS OF UNCERTAINTY: Ibogaine requires careful patient screening and monitoring because of significant safety issues...
March 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38518269/psychedelic-therapy-a-primer-for-primary-care-clinicians-psilocybin
#16
REVIEW
Burton J Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D Beutler, Kirsten Cherian, Viviana D Evans, Chelsey Fasano, Owen S Muir
BACKGROUND: The primary psychoactive drug in magic mushrooms, psilocybin, induces profound alterations in consciousness through the 5-HT2A receptor. This review consolidates current research findings to elucidate the pharmacology, safety profile, and clinical applications of psilocybin. AREAS OF UNCERTAINTY: Despite initial concerns that psilocybin could cause psychosis, contemporary research has demonstrated that psilocybin is generally safe. The most common adverse effects are nausea and headache, yet both tend to be transient...
March 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38518268/psychedelic-therapy-a-primer-for-primary-care-clinicians-n-n-dimethyltryptamine-and-ayahuasca
#17
JOURNAL ARTICLE
Kenneth Shinozuka, Burton J Tabaac, Alejandro Arenas, Bryce D Beutler, Kirsten Cherian, Viviana D Evans, Chelsey Fasano, Owen S Muir
BACKGROUND: N,N-dimethyltryptamine (DMT) is a naturally occurring serotonergic psychedelic found in natural plants around the globe. As the main psychoactive component in ayahuasca, which also contains monoamine oxidase inhibitors, DMT has been consumed as plant-based brew by indigenous peoples for centuries. Further research is required to delineate the therapeutic utility of DMT. AREAS OF UNCERTAINTY: Although previous research has shown that DMT is synthesized endogenously, it may not be produced at physiologically relevant concentrations...
March 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38518267/psychedelic-therapy-a-primer-for-primary-care-clinicians-lysergic-acid-diethylamide-lsd
#18
JOURNAL ARTICLE
Bryce D Beutler, Kenneth Shinozuka, Burton J Tabaac, Alejandro Arenas, Kirsten Cherian, Viviana D Evans, Chelsey Fasano, Owen S Muir
BACKGROUND: Lysergic acid diethylamide (LSD) is a hallucinogenic agent. In the mid-20th century, it was used to augment psychoanalysis and to treat alcohol use disorder. However, LSD was banned in 1970 in part because of concerns that it could bring about or exacerbate mental illness. Its therapeutic potential remains incompletely understood. AREAS OF UNCERTAINTY: While uncontrolled recreational use of LSD can, in rare instances, lead to long-term psychosis, adverse events in clinical trials of LSD, such as anxiety, headache, and nausea, have almost always been mild and transient...
March 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38518266/psychedelic-therapy-a-primer-for-primary-care-clinicians-historical-perspective-and-overview
#19
JOURNAL ARTICLE
Burton J Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D Beutler, Kirsten Cherian, Viviana D Evans, Chelsey Fasano, Owen S Muir
BACKGROUND: Psychedelic drugs have recently emerged as plausibly effective pharmacological agents for the management of depression, anxiety, and other neuropsychiatric conditions, including those that are treatment-resistent. The latter half of the 20th century marked a revolution in the treatment of mental illnesses, exemplified by the introduction of selective serotonin reuptake inhibitors and other pharmacological agents. Nevertheless, mental illness remains a major public health crisis, affecting nearly one billion individuals worldwide...
March 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38506450/post-transfusion-biotin-labeled-red-blood-cell-survival-studies-in-pediatric-sickle-cell-disease-with-antibodies-of-uncertain-significance
#20
JOURNAL ARTICLE
Marianne E M Yee, Patricia E Zerra, James W McCoy, Mischa L Covington, Sean R Stowell, Clinton H Joiner, Christopher M Lough, Bhaveshkumar B Delvadia, Cassandra D Josephson, John D Roback, Ross M Fasano
BACKGROUND: Red blood cell (RBC) antibodies are common in multiply transfused patients with sickle cell disease (SCD). Unlike RBC alloantibodies, the potential of autoantibodies to cause post-transfusion hemolysis may be uncertain. Biotin-labeling provides a direct measurement of red cell survival (RCS) over time, thus can be used to assess the clinical significance of RBC antibodies. Antibodies to biotinylated RBC (B-RBC) occasionally are detected after exposure, which may impact B-RBC survival in subsequent RCS studies...
March 20, 2024: Transfusion
keyword
keyword
46206
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.